Clinical Trials Directory

Trials / Unknown

UnknownNCT02203409

Laparoscopic Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy

Status
Unknown
Phase
Study type
Observational
Enrollment
30 (estimated)
Sponsor
Shuguo Zheng, MD · Academic / Other
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Not accepted

Summary

The purpose of this research is evaluate the results with laparoscopic ALPPS procedure in a single center. The validity, feasibility and limitations were assessed objectively through our clinical prospective study.The investigators expect laparoscopic ALPPS is safe, effective and feasible.

Detailed description

Background: Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) is a breakthrough in the field of hepatobiliary surgery in recent years,which stimulates the remnant liver volume(RLV) grew by 74%-87.2% in 9 to 13 days。The published literature reported that the two stages of ALPPS are the conventional laparotomy surgery,Patients need to undergo the injury of two open operations in a short time. The incidence of postoperative complications and mortality rate is as high as 53% -73% and 12%-27%.The aim of this study was to evaluate the results with laparoscopic ALPPS procedure in a single center, with special emphasis in validity, feasibility and limitations. Results: Clinical data include: operation time, intraoperative blood loss, volume of blood transfusion, complications and mortality, postoperative liver function, long-term curative effect and survival time were collected and analysed. Statistical method:groups t-test ,univariate/multivariate analysis, logistic regression analysis, mixed linear regression, Cox survival analysis ,Kaplan-Meier survival analysis,Log-rank survival curves were used.

Conditions

Interventions

TypeNameDescription
PROCEDURELaparoscopic ALPPSLaparoscopic Associating Liver Partition and Portal Vein Ligation for Two-stage Hepatectomy

Timeline

Start date
2014-07-01
Primary completion
2022-08-01
Completion
2022-08-01
First posted
2014-07-29
Last updated
2022-01-14

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT02203409. Inclusion in this directory is not an endorsement.